Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Key facts

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd

Intervention

LT3001 Drug:high dose(drug)

Enrollment

300 target

Eligibility

18-80 years · All sexes

Timeline

2023 – 2026

Study locations (28)

• Beijing Luhe Hospital Capital Medical University, Beijing, Beijing Municipality, China
• The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China
• Luoyang Third People's Hospital, Luoyang, He'nan, China
• Harrison International Peace Hospital, Hengshui, Hebei, China
• Daqing Oilfield General Hospital, Daqing, Heilongjiang, China
• Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
• The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China
• Inner Mongolia Baogang Hospital, Baotou, Inner Mongolia, China
• Huai'an Second People's Hospital, Huai'an, Jiangsu, China
• The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
• The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
• Pingxiang People's Hospital, Pingxiang, Jiangxi, China
• The First Bethune Hospital of Jilin University, Changchun, Jilin, China
• Beipiao Central Hospital, Chaoyang, Liaoning, China
• Liaocheng People's Hospital, Liaocheng, Shandong, China
• +13 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Androgen insensitivity syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07556042
  Machine Learning Prediction of Disease Progression in Adolescent Idiopathic Scoliosis
  Istanbul University
• RECRUITINGPHASE3NCT07520565
  A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
  Biocells (Beijing) Biotech Co.,Ltd
• RECRUITINGNANCT07321600
  Resisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth Exercises
  Hacettepe University
• RECRUITINGPHASE2, PHASE3NCT07003386
  Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke
  Shanghai Yueyang Integrated Medicine Hospital
• RECRUITINGPHASE2NCT07084012
  A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
  Shenzhen Wingor Biotechnology Co., Ltd.
• RECRUITINGPHASE3NCT07561827
  The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery
  University of California, San Francisco
• ACTIVE NOT RECRUITINGNANCT07194564
  Acute Training Effect Assessment in Adolescent Idiopathic Scoliosis
  The University of Hong Kong
• RECRUITINGNANCT06242821
  Yoga for Back Pain in Adolescent Scoliosis
  Johns Hopkins University

See all trials for Androgen insensitivity syndrome →